Antifungal agents for preventing fungal infections in non-neutropenic critically-ill patients (Q24246969)

https://api.crossref.org/works/10.1002%2F14651858.CD004920

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

Epidemiology of nosocomial fungal infections, with emphasis on Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

Candida infections in critically ill trauma patients: a retrospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Temporal assessment of Candida risk factors in the surgical intensive care unit

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Antifungal prophylaxis for intensive care unit patients: let's fine tune it.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Effects of nosocomial candidemia on outcomes of critically ill patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Systemic candidiasis in intensive care units: A multicenter, matched-cohort study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Prophylactic antifungal therapy in the intensive care unit

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Invasive candidiasis: turning risk into a practical prevention policy?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Antimicrobial Resistance in Hospital Organisms and Its Relation to Antibiotic Use

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Candida colonization and subsequent infections in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

New approaches to the risk of Candida in the intensive care unit

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920

7 January 2021